Atul Sharma

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Hodgkin Lymphoma

Prognostic Factors

Stem Cell Transplantation

Top Venues

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion

Bone marrow transplantation

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Sudhir Kumar, Atul Sharma, Sameer Bakhshi, Deepam Pushpam, Ajay Gogia, Ranjit Kumar Sahoo, Raja Pramanik, Akash Kumar, Neha Pathak, Sanjay Thulkar, Meher Chand Sharma, Ritu Gupta, Soumya Mallick, Vinod Raina
Autologous Stem Cell Transplantation in Adult Hodgkin Lymphoma at a Tertiary Care Center in India: Analysis of Outcomes and Prognostic Factors. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 40 (2) (2023)
Anjali Mookerjee, Ritu Gupta, Rakesh Kumar, Atul Sharma, Ravindra Mohan Pandey, Lalit Kumar
Dual assessment with multiparameter flow cytometry and 18 F-FDG PET/CT scan provides enhanced prediction of measurable residual disease after autologous haemopoietic stem cell transplant in myeloma-a prospective study. Bone marrow transplantation (2023)
Sudhir Kumar, Atul Sharma, Sameer Bakhshi, Deepam Pushpam, Ajay Gogia, Ranjit Kumar Sahoo, Raja Pramanik, Akash Kumar, Neha Pathak, Sanjay Thulkar, Meher Chand Sharma, Ritu Gupta, Soumya Mallick, Vinod Raina
Autologous Stem Cell Transplantation in Adult Hodgkin Lymphoma at a Tertiary Care Center in India: Analysis of Outcomes and Prognostic Factors. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 40 (2) (2023)
Sudhir Kumar, Atul Sharma, Prabhat Singh Malik, Ajay Gogia, Neha Pathak, Ranjit Kumar Sahoo, Ritu Gupta, Chandra Prakash Prasad, Lalit Kumar
Bendamustine in combination with pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: A phase II trial. British journal of haematology 198 (2) (2022)